Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
F-star Therapeutics, Inc (FSTX)  
$7.12 0.00 (0.00%) as of 4:30 Tue 3/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 20,620,000
Market Cap: 146.81(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.12 - $7.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   F-star Therapeutics is a clinical-stage biopharmaceutical company. Co. is engaged in the discovery and development of therapeutics for the treatment of a range of cancers and inflammatory diseases. Co.'s STING (STimulator of INterferon Genes) product portfolio include STING agonist clinical program in oncology, STING antagonist compounds for inflammatory diseases, and STING agonist antibody drug conjugate program for oncology. Co. is developing its SB 11285, as an immunotherapeutic cyclic dinucleotide for the treatment of selected cancers. Co. is also exploring the use of its STING antagonist compounds for the treatment of certain autoimmune and inflammatory diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 134
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-11-23 4 A $9.12 $119,928 D/D 13,150 53,300     -
   Arkowitz David Director   –       •      –    2016-11-23 4 A $9.12 $40,000 D/D 4,386 16,886     -
   Driscoll Martin J President and CEO   •       •      –    2016-11-23 4 A $9.12 $199,728 D/D 21,900 46,400     -
   Brady Todd C Director   –       •      –    2016-11-23 4 A $9.12 $99,992 D/D 10,964 10,964     -
   Freve Jonathan CFO, Treasurer & Secretary   •       •      –    2016-11-23 4 A $9.12 $49,996 D/D 5,482 7,482     -
   Driscoll Martin J President and CEO   •       •      –    2016-11-09 4 B $8.84 $17,680 D/D 2,000 24,500 2.81     -
   Eichler Kurt M Director   –       •      –    2016-11-09 4 B $8.69 $60,830 D/D 7,000 437,990 2.39     -
   Eichler Kurt M Director   –       •      –    2016-09-19 4 B $12.50 $16,825 D/D 1,346 430,990 2.39     -
   Eichler Kurt M Director   –       •      –    2016-09-16 4 B $12.50 $8,125 D/D 650 429,644 2.39     -
   Eichler Kurt M Director   –       •      –    2016-09-14 4 B $12.50 $6,425 D/D 514 428,994 2.39     -
   Eichler Kurt M Director   –       •      –    2016-09-13 4 B $12.50 $6,125 D/D 490 428,480 2.39     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-09-09 4 B $12.50 $30,000 D/D 2,400 40,150 2.74     -
   Driscoll Martin J President and CEO   •       •      –    2016-09-02 4 B $11.75 $11,750 D/D 1,000 22,500 2.81     -
   Driscoll Martin J President and CEO   •       •      –    2016-08-30 4 B $12.41 $12,410 D/D 1,000 21,500 2.81     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-08-24 4 B $11.90 $23,844 D/D 2,000 37,750 2.74     -
   Eichler Kurt M Director   –       •      –    2016-08-23 4 B $10.73 $32,190 D/D 3,000 427,990 2.39     -
   Freve Jonathan CFO, Treasurer & Secretary   •       –      –    2016-08-23 4 B $10.74 $10,740 D/D 1,000 2,000 2.74     -
   Driscoll Martin J President and CEO   •       •      –    2016-08-22 4 B $11.66 $11,660 D/D 1,000 20,500 2.81     -
   Driscoll Martin J President and CEO   •       •      –    2016-08-19 4 B $11.20 $11,200 D/D 1,000 19,500 2.81     -
   Driscoll Martin J President and CEO   •       •      –    2016-08-16 4 B $11.37 $11,370 D/D 1,000 18,500 2.81     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-08-16 4 B $11.49 $1,149 D/D 100 35,750 2.66     -
   Driscoll Martin J President and CEO   •       •      –    2016-08-15 4 B $11.20 $11,200 D/D 1,000 17,500 2.81     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-08-15 4 B $11.43 $20,574 D/D 1,800 35,650 2.74     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-08-12 4/A B $11.32 $11,318 D/D 1,000 33,850 2.74     -
   Afdhal Nezam H. Chief Medical Officer   •       –      –    2016-08-12 4 B $11.33 $29,450 D/D 2,600 33,850 2.74     -
  134 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us